Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
TREATMENT OF ADDICTION QU. WHAT ARE THE CAUSES OF ADDICTION? ZINBERG, (1984) THE DRUG Addiction is a complex interaction THE PERSON THE ENVIRONMENT QU. WHAT ARE THE TREATMENTS FOR ADDICTION? WEST (2006) - INTERACTIONIST MODEL Susceptibility INITIATION Social factors beliefs held MAINTENANCE Doctors help Clinical interventions CESSATION abstinence Self help Community support Workplace rules SOME CONSIDERATIONS IN TREATMENT; Prevention Once is better than cure! addicted, group & individual approaches used. The more holistic approach = better recovery rate. Addiction and mental health issues are interlinked and can affect appropriate treatments used. Lots of research opportunities! QU. READY TO WATCH A BBC FILM? http://www.youtube.com/watch?v=GowvCVSnAfY&feat ure=player_embedded#! QU. WHY DO WE GIVE PATIENTS DRUGS? Key brain pathways are involved addictions. Prolonged addictive behaviours are associated with changes in brain function Brain changes demonstrated at molecular, cellular, structural and functional levels. This evidence provides a rationale for medicationassisted treatment of addiction DRUG TREATMENTS FOR NICOTINE? Chantix™ (Varenicline) Nicotine Replacement NON-NICOTINE DRUG AIDS (VARENICLINE) Nicotine attaches to brain receptors & sends a message to a different part of the brain to release dopamine = pleasure feeling for a short time. This drug works by activating these receptors and blocking nicotine from attaching to them. Thus smoking is not reinforcement or a reward for smokers (antagonist effect). MEDICATIONS FOR TREATMENT OF ALCOHOLISM Disulfiram (Antabuse) Naltrexone (and many more!) ANTABUSE Used to support the treatment of chronic alcohol abuse by producing an acute sensitivity to alcohol Initial dose is 500 mg for 1 to 2 weeks, followed by a maintenance dose of 250 mg (range 125 mg 500 mg) per day. The total daily dosage should not exceed 500 mg. Should not be taken if alcohol has been consumed in the last 12 hours. NALTREXONE By blocking the opioid receptors, and weakens the rewarding effects of alcohol and reduces dopamine release and the inhibitory GABAergic output. (Blocks the “high” feeling) Appears Dose: to promote reduction in drinking level 50 mg per day. METHADONE Long lasting synthetic opiate administered orally to prevent withdrawal symptoms. Methadone stimulates the same receptor sites as heroin but in a milder way. It stops the craving for opiates but doesn’t get the user ‘high’. Do they work? SMOKING QUIT RATES* WITH DRUGS Quit Rates = Continuous abstinence (not even one puff of a cigarette) during weeks 9-12 CHANTIX 1 mg bid Zyban 150 mg bid Placebo Gonzales et al 44.0%* (n=1025) 29.5%† 17.7% Jorenby et al (n=1027) 29.8%‡ 17.6% 43.9%* Median Heavy Drinking Days per Month for Each Treatment Group Overall and by Sex Garbett et al, 2005 Garbutt, J. C. et al. JAMA 2005;293:1617-1625. Copyright restrictions may apply. REDUCTION OF HEROIN USE BY DURATION OF METHADONE TREATMENT Ball & Ross, 1991. 120 100 97% P e 80 r c 60 e n 40 t 67% 23% 20 0 8% Pretreatment Admission: < 6 months stay Average Stay: 6 to 54 months Long-term: > 54 months QU. ANY LIMITATION WITH DRUG TREATMENT? The most frequently reported adverse events for nicotine drugs (>10%) were nausea, headache, insomnia and abnormal dreams. Antabuse may cause liver toxicity. Methadone? RETURN TO I.V. DRUG USE FOLLOWING TERMINATION OF METHADONE TREATMENT 90% 80% % I V 82.1% 70% 72.7% 60% 57.6% 50% U S E R S 40% 45.5% 30% 20% 28.9% 10% 0% In Tx. 1 to 3 4 to 6 Months Since Dropout 7 to 9 10 to 12 Primary Drug at Entry to Opiate Treatment, King County WA 100.0 94.6 Heroin 80.0 83.2 60.0 % 40.0 20.0 14.4 Rx Opiate 3.0 0.0 1999 2000 2001 2002 2003 2004 2005 QU. ANY OTHER LIMITATIONS? Qu. Would they work for Behavioural addictions? Such as porn addictions? Or food addictions? MARK GRIFFITHS (2012)